★ Sign in to follow
DC

D Connor

GB·RNS (LSE)
GlaxoSmithKline plc
Total declarations
14
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (2 ops.)
€554k

Latest filing published 11 Oct 2019 for GlaxoSmithKline plc, €9,711.

Filing timeline

BuySale
D Connor

Insider track record

Disclosed buys
0
Disclosed sells
2
Signal history

D Connor: trading record in brief

D Connor appears in our data through filings on GlaxoSmithKline plc shares, published by RNS (LSE). Between 14 July 2016 and 10 October 2019, the trades on record add up to 14 filings.

Every open-market trade on record is a sale: 2 sales worth €554k. Besides market trades, the filings include 11 share grants. In 2019 alone, the filings show no purchases and 1 sale.

On 11 October 2019 came the latest disclosure, a share grant for €9,711 in GlaxoSmithKline plc. Filings reach the RNS (LSE) feed a median of 1 day after the trade. The regulation allows three business days to notify a trade (UK MAR). Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.

Companies and markets linked to D Connor

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations14 total
  • ◆
    D Connor
    PCA of Mr R G Connor (President, Global Vaccines)ExecutivesGlaxoSmithKline plc
    8,601 GBP15FCA-NSM
    500 shares@ £17.2029100.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20191011161001_14263725_20200326185154351_23377-3
  • ◆
    D Connor
    PCA of Mr R G Connor (President, Global Vaccines)ExecutivesGlaxoSmithKline plc
    8,492 GBP7FCA-NSM
    514 shares@ £16.52231.5% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20190712163526_14147423_20200326185124019_23194-3
  • ◆
    D Connor
    PCA of Mr R G Connor (President, Global Vaccines)ExecutivesGlaxoSmithKline plc
    10,148 GBP7FCA-NSM
    645 shares@ £15.73352.6% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20190412163342_14040049_20200326185043398_13787-2
  • ▼
    D Connor
    PCA of Mr R G Connor (President, Global Vaccines)ExecutivesGlaxoSmithKline plc
    360,673 GBP30FCA-NSM
    23,205 shares@ £15.542991.8% of flowLondon Stock Exchange ( XLON)ISIN GB0009252882FCA-NSM:LSE20190211124250_13965121_20200326185110102_19460
  • ◆
    D Connor
    PCA of Mr R G Connor (President, Global Manufacturing & Supply)ExecutivesGlaxoSmithKline plc
    13,379 GBP7FCA-NSM
    851 shares@ £15.72183.4% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20180713161604_13717916_20200330111420498_14427-2
  • ◆
    D Connor
    PCA of Mr R G Connor (President, Global Manufacturing & Supply)ExecutivesGlaxoSmithKline plc
    4,923 GBP7FCA-NSM
    342 shares@ £14.3940.9% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20180413155025_13604520_20200330111353856_14272-2
  • ◆
    D Connor
    PCA of Mr R G Connor (President, Global Manufacturing & Supply)ExecutivesGlaxoSmithKline plc
    4,002 GBP7FCA-NSM
    300 shares@ £13.34090.7% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20180115090455_13496097_20200330111417253_16400-2
  • ◆
    D Connor
    PCA of Mr R G Connor (President, Global Manufacturing & Supply)ExecutivesGlaxoSmithKline plc
    3,954 GBP7FCA-NSM
    259 shares@ £15.26590.7% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20171013162035_13396747_20200330131537789_9821-2
  • ◆
    D Connor
    PCA of Mr R G Connor (President, Global Manufacturing & Supply)ExecutivesGlaxoSmithKline plc
    3,827 GBP7FCA-NSM
    236 shares@ £16.21650.7% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20170714115754_13295823_20200330131517271_10943-2
  • ●
    D Connor
    PCA of Mr R G Connor (President, Global Manufacturing & Supply)ExecutivesGlaxoSmithKline plc
    0FCA-NSM
    7,875 sharesn/aISIN GB0009252882FCA-NSM:LSE20170531162548_13244514_20200330131531595_24519-1
  • ▼
    D Connor
    PCA of Mr R G Connor (President, Global Manufacturing & Supply)ExecutivesGlaxoSmithKline plc
    122,048 GBP24FCA-NSM
    7,435 shares@ £16.415323.4% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20170522164003_13234314_20200330131531274_17370-1
  • ◆
    D Connor
    PCA of Mr R G Connor (President, Global Manufacturing & Supply)ExecutivesGlaxoSmithKline plc
    4,583 GBP7FCA-NSM
    279 shares@ £16.42690.9% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20170419163423_13197777_20200330131500011_12349-1
  • ◆
    D Connor
    PCA of Mr R G Connor (President, Global Manufacturing & Supply)ExecutivesGlaxoSmithKline plc
    3,697 GBP7FCA-NSM
    217 shares@ £17.03890.7% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20161014171057_013001974_20200330143616319_11065-6
  • ◆
    D Connor
    PCA of Mr R G Connor (President, Global Manufacturing & Supply)ExecutivesGlaxoSmithKline plc
    3,649 GBP7FCA-NSM
    220 shares@ £16.58750.7% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:LSE20160718165957_012896743_20200330143558405_13591

14 of 14 declarations

Related entities

No related entities found.